InsidersTradesSigma
Follow the 诚达药业 share price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 诚达药业 has logged 1 reports. Market capitalisation: €4.2bn. The latest transaction was disclosed on 21 January 2022 (Sale). Among the most active insiders: 陈小红. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Chengda Pharmaceutical es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XSHE. Se enfoca en el desarrollo y producción de medicamentos innovadores.